GlycoMimetics (GLYC)

Add to Watchlists
Create an Alert
14.36 +0.57  +4.13% NASDAQ Apr 16, 5:00PM BATS Real time Currency in USD
View Full Chart
GLYC Price Chart
View All Performance Charts

GLYC Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). GlycoMimetics is up N/A over the last year vs S&P 500 Total Return up 22.52%, Ultragenyx Pharmaceutical up N/A, and uniQure up N/A.

Get Quote for

Portfolio Strategies Featuring GLYC

Did GlycoMimetics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

GLYC Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Maryland
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

GlycoMimetics Inc is a clinical stage biotechnology company engaged in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role.

Recent Quotes

Symbol Price Chg Chg % Market Cap
GLYC 14.36 +0.57 +4.13% 267.19M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.